Project Number GC-2013127 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2016 View Full Project Details for Phase I clinical trials of a novel neurotrophic activator drug to treat Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) l. Growth Factors and Hormones Researcher and Organization Principal Investigator Kawas, Leen Principal Investigator First Name Leen Principal Investigator Last Name Kawas Awardee Organization M3 Biotechnology, Inc. Awardee State Washington Contact PI Country United States Project Detail Funding Opportunity Announcement PACT Program FY Overall Cost $1,397,630 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
